In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D.

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

Researchers have bioprinted human islets designed to mimic the body’s own tissue structure, allowing them to integrate ...

A global research team, led by Wake Forest University’s Dr. Quentin Perrier, has successfully 3D-printed functioning human ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

By Nancy Lapid (Reuters) -Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported ...

Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...

In people with Type 2 diabetes, the body does not make or use insulin well, and so insulin therapy may be needed. Insulin can be administered using a needle and syringe, a pen injection, a pump ...

Insulin therapy for Type 2 diabetes. Diabetes is a condition in which your pancreas fails to secrete a sufficient amount of insulin to help you to maintain normal blood glucose, or sugar in the ...

Intensive insulin therapy reduced the cumulative TISS-28 scores among patients in the ICU by 20 percent (454±22 in the conventional-treatment group vs. 388±17 in the intensive-treatment group, ...